盆腔器官脱垂手术后女性复发、并发症及健康状况预测模型
基于盆底疾病网络三项随机试验和两项前瞻性队列研究共1301例接受顶端脱垂手术的参与者,开发逻辑回归模型预测术后12个月复发、并发症及健康状况变化;模型对复合复发脱垂、阴道膨出症状、处女膜外脱垂的区分度较好,对严重不良事件和健康状况变化的区分度中等,校准曲线显示预测概率临床可用。
要点
- 模型预测复合复发脱垂的concordance index为0.72(95% CI 0.69-0.76)。
- 模型预测严重不良事件的concordance index为0.60(95% CI 0.56-0.64)。
- 校准曲线显示所有模型在临床有用的预测概率范围内准确。
核心结论
- 这些预测模型能够对脱垂手术后12个月的脱垂复发、并发症和健康状况提供准确且有区分度的估计。
研究设计与样本
- 使用盆底疾病网络开展的三项随机试验和两项前瞻性队列研究组成的联合队列,共1301例参与者,开发逻辑回归模型。
- 每个模型考虑32个候选危险因素,模型准确性用concordance index衡量,所有指数通过1000次bootstrap重抽样进行内部验证以校正偏倚。
主要发现
- 复合复发脱垂定义为术后12个月内脱垂超过处女膜、存在困扰性膨出症状或脱垂再手术或再治疗。
- 并发症定义为术后12个月内任何严重不良事件或Dindo III级并发症。
- 健康状况显著变化定义为SF-6D效用评分较基线达到最小重要变化(±0.035分)。
- 模型预测复合复发脱垂的concordance index=0.72(95% CI 0.69-0.76),困扰性阴道膨出的concordance index=0.73(95% CI 0.68-0.77),脱垂超过处女膜的concordance index=0.74(95% CI 0.70-0.77)。
- 模型预测严重不良事件的concordance index=0.60(95% CI 0.56-0.64),Dindo III级或以上并发症的concordance index=0.62(95% CI 0.58-0.66),健康状况改善的concordance index=0.64(95% CI 0.62-0.67),健康状况恶化的concordance index=0.63(95% CI 0.60-0.67)。
关键数值与推荐
- 复合复发脱垂:术后12个月内脱垂超过处女膜、存在困扰性膨出症状或脱垂再手术或再治疗。
- 并发症:术后12个月内任何严重不良事件或Dindo III级并发症。
- 健康状况显著变化:SF-6D效用评分较基线变化±0.035分。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop statistical models predicting recurrent pelvic organ prolapse, surgical complications, and change in health status 12 months after apical prolapse surgery. METHODS: Logistic regression models were developed using a combined cohort from three randomized trials and two prospective cohort studies from 1,301 participants enrolled in surgical studies conducted by the Pelvic Floor Disorders Network. Composite recurrent prolapse was defined as prolapse beyond the hymen; the presence of bothersome bulge symptoms; or prolapse reoperation or retreatment within 12 months after surgery. Complications were defined as any serious adverse event or Dindo grade III complication within 12 months of surgery. Significant change in health status was defined as a minimum important change of SF-6D utility score (±0.035 points) from baseline. Thirty-two candidate risk factors were considered for each model and model accuracy was measured using concordance indices. All indices were internally validated using 1,000 bootstrap resamples to correct for bias. RESULTS: The models accurately predicted composite recurrent prolapse (concordance index=0.72, 95% CI 0.69-0.76), bothersome vaginal bulge (concordance index=0.73, 95% CI 0.68-0.77), prolapse beyond the hymen (concordance index=0.74, 95% CI 0.70-0.77), serious adverse event (concordance index=0.60, 95% CI 0.56-0.64), Dindo grade III or greater complication (concordance index=0.62, 95% CI 0.58-0.66), and health status improvement (concordance index=0.64, 95% CI 0.62-0.67) or worsening (concordance index=0.63, 95% CI 0.60-0.67). Calibration curves demonstrated all models were accurate through clinically useful predicted probabilities. CONCLUSION: These prediction models are able to provide accurate and discriminating estimates of prolapse recurrence, complications, and health status 12 months after prolapse surgery.
引用
- Jelovsek JE, Chagin K, Lukacz ES, et al. Models for Predicting Recurrence, Complications, and Health Status in Women After Pelvic Organ Prolapse Surgery. Obstet Gynecol. 2018. PMID: 29995735. doi:10.1097/AOG.0000000000002750
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。